Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 2
1986 2
1987 1
1988 1
1989 1
1990 1
1993 1
1994 2
1995 7
1996 7
1997 6
1998 4
1999 7
2000 8
2001 10
2002 13
2003 15
2004 24
2005 11
2006 12
2007 14
2008 14
2009 18
2010 16
2011 22
2012 20
2013 19
2014 15
2015 13
2016 13
2017 11
2018 9
2019 7
2020 11
2021 15
2022 6
2023 3
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

336 results

Results by year

Filters applied: . Clear all
Page 1
Current and future therapies for type 1 diabetes.
von Scholten BJ, Kreiner FF, Gough SCL, von Herrath M. von Scholten BJ, et al. Among authors: von herrath m. Diabetologia. 2021 May;64(5):1037-1048. doi: 10.1007/s00125-021-05398-3. Epub 2021 Feb 17. Diabetologia. 2021. PMID: 33595677 Free PMC article. Review.
Efficacy and safety of liraglutide in type 1 diabetes by baseline characteristics in the ADJUNCT ONE and ADJUNCT TWO randomized controlled trials.
Dejgaard TF, von Scholten BJ, Christiansen E, Kreiner FF, Bardtrum L, von Herrath M, Mathieu C, Madsbad S; ADJUNCT ONE and ADJUNCT TWO Investigators. Dejgaard TF, et al. Among authors: von herrath m. Diabetes Obes Metab. 2021 Dec;23(12):2752-2762. doi: 10.1111/dom.14532. Epub 2021 Sep 28. Diabetes Obes Metab. 2021. PMID: 34463425 Free PMC article. Clinical Trial.
Anti-interleukin-21 antibody and liraglutide for the preservation of β-cell function in adults with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled, phase 2 trial.
von Herrath M, Bain SC, Bode B, Clausen JO, Coppieters K, Gaysina L, Gumprecht J, Hansen TK, Mathieu C, Morales C, Mosenzon O, Segel S, Tsoukas G, Pieber TR; Anti-IL-21–liraglutide Study Group investigators and contributors. von Herrath M, et al. Lancet Diabetes Endocrinol. 2021 Apr;9(4):212-224. doi: 10.1016/S2213-8587(21)00019-X. Epub 2021 Mar 1. Lancet Diabetes Endocrinol. 2021. PMID: 33662334 Clinical Trial.
Liraglutide protects β-cells in novel human islet spheroid models of type 1 diabetes.
Yesildag B, Mir-Coll J, Neelakandhan A, Gibson CB, Perdue NR, Rufer C, Karsai M, Biernath A, Forschler F, Jin PW, Misun PM, Title A, Hierlemann A, Kreiner FF, Wesley JD, von Herrath MG. Yesildag B, et al. Among authors: von herrath mg. Clin Immunol. 2022 Nov;244:109118. doi: 10.1016/j.clim.2022.109118. Epub 2022 Sep 6. Clin Immunol. 2022. PMID: 36084852
Regulatory Immune Mechanisms beyond Regulatory T Cells.
Christoffersson G, von Herrath M. Christoffersson G, et al. Among authors: von herrath m. Trends Immunol. 2019 Jun;40(6):482-491. doi: 10.1016/j.it.2019.04.005. Epub 2019 May 14. Trends Immunol. 2019. PMID: 31101537 Review.
Viruses and diabetes.
Jaeckel E, Manns M, Von Herrath M. Jaeckel E, et al. Among authors: von herrath m. Ann N Y Acad Sci. 2002 Apr;958:7-25. doi: 10.1111/j.1749-6632.2002.tb02943.x. Ann N Y Acad Sci. 2002. PMID: 12021080 Review.
Recent advances in understanding Type 1 Diabetes.
Christoffersson G, Rodriguez-Calvo T, von Herrath M. Christoffersson G, et al. Among authors: von herrath m. F1000Res. 2016 Jan 27;5:F1000 Faculty Rev-110. doi: 10.12688/f1000research.7356.1. eCollection 2016. F1000Res. 2016. PMID: 26918165 Free PMC article. Review.
Virus-induced autoimmune disease.
von Herrath MG, Oldstone MB. von Herrath MG, et al. Curr Opin Immunol. 1996 Dec;8(6):878-85. doi: 10.1016/s0952-7915(96)80019-7. Curr Opin Immunol. 1996. PMID: 8994870 Free PMC article. Review.
336 results